0000766704false2023Q1December 31P1Yhttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#LeaseRightOfUseAssethttp://www.welltower.com/20230331#ReceivablesAndOtherAssetshttp://www.welltower.com/20230331#ReceivablesAndOtherAssetshttp://fasb.org/us-gaap/2022#RealEstateHeldforsalehttp://fasb.org/us-gaap/2022#RealEstateHeldforsalehttp://www.welltower.com/20230331#LeaseLiabilityhttp://www.welltower.com/20230331#LeaseLiabilityhttp://www.welltower.com/20230331#LeaseLiabilityhttp://www.welltower.com/20230331#LeaseLiabilityP3Y00007667042023-01-012023-03-310000766704us-gaap:CommonStockMember2023-01-012023-03-310000766704well:GuaranteeNotesDue20284800Member2023-01-012023-03-310000766704well:GuaranteeNotesDue20344500Member2023-01-012023-03-3100007667042023-04-28xbrli:shares00007667042023-03-31iso4217:USD00007667042022-12-310000766704us-gaap:ManagementServiceMember2023-01-012023-03-310000766704us-gaap:ManagementServiceMember2022-01-012022-03-3100007667042022-01-012022-03-310000766704well:InterestRevenueMember2023-01-012023-03-310000766704well:InterestRevenueMember2022-01-012022-03-310000766704us-gaap:ProductAndServiceOtherMember2023-01-012023-03-310000766704us-gaap:ProductAndServiceOtherMember2022-01-012022-03-31iso4217:USDxbrli:shares0000766704us-gaap:CommonStockMember2022-12-310000766704us-gaap:AdditionalPaidInCapitalMember2022-12-310000766704us-gaap:TreasuryStockCommonMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-12-310000766704well:AccumulatedDistributionsMember2022-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310000766704us-gaap:NoncontrollingInterestMember2022-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-01-012023-03-310000766704us-gaap:NoncontrollingInterestMember2023-01-012023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-01-012023-03-310000766704us-gaap:TreasuryStockCommonMember2023-01-012023-03-310000766704well:AccumulatedDistributionsMember2023-01-012023-03-310000766704us-gaap:CommonStockMember2023-03-310000766704us-gaap:AdditionalPaidInCapitalMember2023-03-310000766704us-gaap:TreasuryStockCommonMember2023-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2023-03-310000766704well:AccumulatedDistributionsMember2023-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000766704us-gaap:NoncontrollingInterestMember2023-03-310000766704us-gaap:CommonStockMember2021-12-310000766704us-gaap:AdditionalPaidInCapitalMember2021-12-310000766704us-gaap:TreasuryStockCommonMember2021-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2021-12-310000766704well:AccumulatedDistributionsMember2021-12-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310000766704us-gaap:NoncontrollingInterestMember2021-12-3100007667042021-12-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-01-012022-03-310000766704us-gaap:NoncontrollingInterestMember2022-01-012022-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310000766704us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310000766704us-gaap:CommonStockMember2022-01-012022-03-310000766704us-gaap:TreasuryStockCommonMember2022-01-012022-03-310000766704well:AccumulatedDistributionsMember2022-01-012022-03-310000766704us-gaap:CommonStockMember2022-03-310000766704us-gaap:AdditionalPaidInCapitalMember2022-03-310000766704us-gaap:TreasuryStockCommonMember2022-03-310000766704us-gaap:RetainedEarningsUnappropriatedMember2022-03-310000766704well:AccumulatedDistributionsMember2022-03-310000766704us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310000766704us-gaap:NoncontrollingInterestMember2022-03-3100007667042022-03-310000766704well:WelltowerOPIncMember2023-01-012023-03-31xbrli:pure0000766704well:WelltowerOPIncMember2023-03-310000766704well:OtherInvestorsMemberwell:WelltowerOPIncMember2023-03-310000766704well:SeniorHousingOperatingMemberwell:COVID19Member2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberwell:COVID19Member2022-01-012022-03-310000766704well:SeniorHousingOperatingMember2023-03-310000766704well:TripleNetMember2023-03-310000766704well:OutpatientMedicalMember2023-03-310000766704well:SeniorHousingOperatingMember2022-03-310000766704well:TripleNetMember2022-03-310000766704well:OutpatientMedicalMember2022-03-310000766704well:SeniorHousingOperatingMember2023-01-012023-03-310000766704well:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMember2022-01-012022-03-310000766704well:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMember2022-01-012022-03-310000766704well:HolidayRetirementMember2022-04-01well:property00007667042022-04-012022-04-010000766704us-gaap:OtherIncomeMember2022-04-012022-06-300000766704us-gaap:LeasesAcquiredInPlaceMember2023-03-310000766704us-gaap:LeasesAcquiredInPlaceMember2022-12-310000766704us-gaap:AboveMarketLeasesMember2023-03-310000766704us-gaap:AboveMarketLeasesMember2022-12-310000766704well:LeaseCommissionsMember2023-03-310000766704well:LeaseCommissionsMember2022-12-310000766704us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember2023-03-310000766704us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2023-01-012023-03-310000766704us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2022-01-012022-03-310000766704srt:MinimumMember2023-01-012023-03-310000766704srt:MaximumMember2023-01-012023-03-310000766704us-gaap:CostOfSalesMember2023-01-012023-03-310000766704us-gaap:CostOfSalesMember2022-01-012022-03-310000766704us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-03-310000766704us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMember2023-03-310000766704us-gaap:OperatingSegmentsMember2022-12-310000766704us-gaap:CorporateNonSegmentMember2023-03-310000766704us-gaap:CorporateNonSegmentMember2022-12-310000766704well:OperatingSegmentsAndCorporateNonSegmentMember2023-03-310000766704well:OperatingSegmentsAndCorporateNonSegmentMember2022-12-310000766704us-gaap:MortgageReceivablesMember2023-03-310000766704us-gaap:MortgageReceivablesMember2022-12-310000766704well:OtherRealEstateLoansReceivablesMember2023-03-310000766704well:OtherRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:RealEstateLoanMember2023-03-310000766704us-gaap:RealEstateLoanMember2022-12-310000766704well:DeterioratedLoansMember2023-03-31well:loan0000766704well:CollectiveLoanPool1Member2023-03-310000766704well:CollectiveLoanPool2Member2023-03-310000766704well:CollectiveLoanPool3Member2023-03-310000766704well:CollectiveLoanPool4Member2023-03-310000766704well:CollectiveLoanPool5Member2023-03-310000766704well:CollectiveLoanPool6Member2023-03-310000766704us-gaap:RealEstateLoanMember2023-03-310000766704well:SeniorsHousingOperatingMembersrt:MinimumMember2023-03-310000766704well:SeniorsHousingOperatingMembersrt:MaximumMember2023-03-310000766704well:SeniorsHousingOperatingMember2023-03-310000766704well:SeniorsHousingOperatingMember2022-12-310000766704well:TripleNetMembersrt:MinimumMember2023-03-310000766704well:TripleNetMembersrt:MaximumMember2023-03-310000766704well:TripleNetMember2023-03-310000766704well:TripleNetMember2022-12-310000766704well:OutpatientMedicalMembersrt:MinimumMember2023-03-310000766704srt:MaximumMemberwell:OutpatientMedicalMember2023-03-310000766704well:OutpatientMedicalMember2023-03-310000766704well:OutpatientMedicalMember2022-12-310000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-03-31well:properties0000766704us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:IntegraHealthcarePropertiesMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:IntegraHealthcarePropertiesMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:SunriseSeniorLivingMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:SunriseSeniorLivingMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:CogirManagementCorporationMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:CogirManagementCorporationMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:StoryPointSeniorLivingMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:StoryPointSeniorLivingMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:HCOneGroupMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:HCOneGroupMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:RemainingPortfolioMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMemberwell:RemainingPortfolioMember2023-01-012023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMember2023-03-310000766704us-gaap:CreditConcentrationRiskMemberwell:NetOperatingingIncomeMember2023-01-012023-03-310000766704well:HCOneGroupMember2023-03-31iso4217:GBPwell:bank0000766704us-gaap:RevolvingCreditFacilityMember2023-03-310000766704well:TermCreditFacilityMember2023-03-310000766704well:TermCreditFacilityCADDenominatedMember2023-03-31iso4217:CAD0000766704us-gaap:RevolvingCreditFacilityMemberwell:CreditFacilityTrancheDue2026Member2023-03-310000766704us-gaap:RevolvingCreditFacilityMemberwell:CreditFacilityTrancheDue2025Member2023-03-31well:Term0000766704us-gaap:RevolvingCreditFacilityMember2023-01-012023-03-310000766704us-gaap:RevolvingCreditFacilityMemberwell:AccordionfeaturememberMember2023-03-310000766704well:TermCreditFacilityCADDenominatedMemberwell:AccordionfeaturememberMember2023-03-310000766704us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-03-310000766704us-gaap:CommercialPaperMembersrt:MaximumMember2023-01-012023-03-310000766704us-gaap:CommercialPaperMember2023-03-310000766704us-gaap:UnsecuredDebtMember2023-03-310000766704us-gaap:SecuredDebtMember2023-03-310000766704us-gaap:UnsecuredDebtMembersrt:MinimumMember2023-03-310000766704us-gaap:UnsecuredDebtMembersrt:MaximumMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:A295SeniorUnsecuredNotesDue2023Member2023-03-310000766704us-gaap:SecuredDebtMembersrt:MinimumMember2023-03-310000766704srt:MaximumMemberus-gaap:SecuredDebtMember2023-03-310000766704well:UnsecuredTermCreditFacilityMaturesJuly192023Memberus-gaap:UnsecuredDebtMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2023-03-31well:term0000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMember2023-01-012023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-01-012023-03-310000766704well:UnsecuredTermCreditFacilityMaturesJuly192023Memberus-gaap:UnsecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberwell:CanadianDealerOfferedRateMember2023-01-012023-03-310000766704us-gaap:UnsecuredDebtMemberwell:TermLoanMemberwell:CanadianDealerOfferedRateMember2023-03-310000766704well:UkDebtDue2028Memberus-gaap:UnsecuredDebtMember2023-03-310000766704us-gaap:UnsecuredDebtMemberwell:A450SeniorUnsecuredNotesDue2034Member2023-03-310000766704us-gaap:UnsecuredDebtMember2022-12-310000766704us-gaap:UnsecuredDebtMember2021-12-310000766704us-gaap:UnsecuredDebtMember2023-01-012023-03-310000766704us-gaap:UnsecuredDebtMember2022-01-012022-03-310000766704us-gaap:UnsecuredDebtMember2022-03-310000766704us-gaap:SecuredDebtMember2022-12-310000766704us-gaap:SecuredDebtMember2021-12-310000766704us-gaap:SecuredDebtMember2023-01-012023-03-310000766704us-gaap:SecuredDebtMember2022-01-012022-03-310000766704us-gaap:SecuredDebtMember2022-03-310000766704us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2022-03-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-03-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-03-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704currency:CADus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704currency:GBPus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-09-300000766704us-gaap:CashFlowHedgingMembercurrency:USDus-gaap:DesignatedAsHedgingInstrumentMember2023-03-310000766704us-gaap:CashFlowHedgingMembercurrency:USDus-gaap:DesignatedAsHedgingInstrumentMember2022-12-310000766704currency:USDus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2023-03-310000766704currency:USDus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueHedgingMember2022-12-310000766704currency:USDus-gaap:NondesignatedMember2023-03-310000766704currency:USDus-gaap:NondesignatedMember2022-12-310000766704currency:CADus-gaap:NondesignatedMember2023-03-310000766704currency:CADus-gaap:NondesignatedMember2022-12-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704us-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-03-310000766704us-gaap:NondesignatedMember2023-01-012023-03-310000766704us-gaap:NondesignatedMember2022-01-012022-03-310000766704us-gaap:WarrantMember2023-01-012023-03-310000766704us-gaap:WarrantMember2022-01-012022-03-310000766704us-gaap:OtherComprehensiveIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-03-310000766704us-gaap:OtherComprehensiveIncomeMemberus-gaap:DesignatedAsHedgingInstrumentMember2022-01-012022-03-31well:obligation0000766704well:CapitalImprovementsMember2023-03-310000766704well:AtTheMarketProgramMember2022-04-300000766704well:AtTheMarketProgramMember2023-03-310000766704us-gaap:AccumulatedTranslationAdjustmentMember2023-03-310000766704us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2023-03-310000766704us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2022-12-310000766704us-gaap:EmployeeStockOptionMember2022-01-012022-03-310000766704us-gaap:MortgagesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000766704us-gaap:MortgagesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000766704us-gaap:MortgagesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704us-gaap:MortgagesMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704well:OtherRealEstateLoansReceivableMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-03-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-03-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMember2022-12-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-03-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2023-03-310000766704us-gaap:CarryingReportedAmountFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:EstimateOfFairValueFairValueDisclosureMemberwell:NonRealEstateLoansReceivablesMember2022-12-310000766704us-gaap:FairValueInputsLevel1Member2023-03-310000766704us-gaap:FairValueInputsLevel2Member2023-03-310000766704us-gaap:FairValueInputsLevel3Member2023-03-310000766704us-gaap:WarrantMember2022-12-310000766704us-gaap:WarrantMember2021-12-310000766704us-gaap:WarrantMember2023-01-012023-03-310000766704us-gaap:WarrantMember2022-01-012022-03-310000766704us-gaap:WarrantMember2023-03-310000766704us-gaap:WarrantMember2022-03-310000766704well:TerminalCapitalizationRateMember2023-03-31well:segment0000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2023-01-012023-03-310000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310000766704us-gaap:CorporateNonSegmentMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberwell:InterestRevenueMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2023-01-012023-03-310000766704well:InterestRevenueMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2023-01-012023-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:TripleNetMember2023-01-012023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2023-01-012023-03-310000766704us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2023-03-310000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2023-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2023-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ManagementServiceMember2022-01-012022-03-310000766704us-gaap:CorporateNonSegmentMemberus-gaap:ManagementServiceMember2022-01-012022-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310000766704us-gaap:CorporateNonSegmentMember2022-01-012022-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberwell:InterestRevenueMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberwell:InterestRevenueMember2022-01-012022-03-310000766704well:InterestRevenueMemberus-gaap:CorporateNonSegmentMember2022-01-012022-03-310000766704well:SeniorHousingOperatingMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-03-310000766704us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMemberwell:TripleNetMember2022-01-012022-03-310000766704well:OutpatientMedicalMemberus-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMember2022-01-012022-03-310000766704us-gaap:ProductAndServiceOtherMemberus-gaap:CorporateNonSegmentMember2022-01-012022-03-310000766704country:US2023-01-012023-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:US2022-01-012022-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:GB2023-01-012023-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:GB2022-01-012022-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:CA2023-01-012023-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:CA2022-01-012022-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:USus-gaap:ManagementServiceMember2023-01-012023-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:USus-gaap:ManagementServiceMember2022-01-012022-03-310000766704country:USus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:GBus-gaap:ManagementServiceMember2023-01-012023-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:GBus-gaap:ManagementServiceMember2022-01-012022-03-310000766704country:GBus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:CAus-gaap:ManagementServiceMember2023-01-012023-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704country:CAus-gaap:ManagementServiceMember2022-01-012022-03-310000766704country:CAus-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2023-01-012023-03-310000766704us-gaap:GeographicConcentrationRiskMemberus-gaap:ManagementServiceMemberus-gaap:SalesRevenueNetMember2022-01-012022-03-310000766704country:US2023-03-310000766704country:USus-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704country:US2022-12-310000766704country:USus-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704country:GB2023-03-310000766704us-gaap:AssetsTotalMembercountry:GBus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704country:GB2022-12-310000766704us-gaap:AssetsTotalMembercountry:GBus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704country:CA2023-03-310000766704us-gaap:AssetsTotalMembercountry:CAus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704country:CA2022-12-310000766704us-gaap:AssetsTotalMembercountry:CAus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704us-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2023-01-012023-03-310000766704us-gaap:AssetsTotalMemberus-gaap:GeographicConcentrationRiskMember2022-01-012022-12-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2023-03-310000766704us-gaap:VariableInterestEntityPrimaryBeneficiaryMember2022-12-31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
| | | | | | | | |
| | |
☑ | | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2023
or
| | | | | | | | |
| | |
☐ | | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number: 1-8923
WELLTOWER INC.
(Exact name of registrant as specified in its charter)
| | | | | | | | | | | | | | | | | |
Delaware | 34-1096634 |
(State or other jurisdiction of Incorporation) | (IRS Employer Identification No.) |
| | | | | |
4500 Dorr Street | Toledo, | Ohio | | 43615 |
(Address of principal executive office) | (Zip Code) |
| | | | | |
(419) - | 247-2800 |
(Registrant’s telephone number, including area code) |
| | | | | |
Not Applicable |
(Former name, former address and former fiscal year, if changed since last report) |
| | | | | | | | |
Securities registered pursuant to Section 12(b) of the Act |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Common stock, $1.00 par value per share | WELL | New York Stock Exchange |
Guarantee of 4.800% Notes due 2028 issued by Welltower OP LLC | WELL/28 | New York Stock Exchange |
Guarantee of 4.500% Notes due 2034 issued by Welltower OP LLC | WELL/34 | New York Stock Exchange |
| | |
| | |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨
Indicate by check mark whether the registrant has submitted electronically, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Large accelerated filer | þ | Accelerated filer | ¨ | Non-accelerated filer | ¨ | Smaller reporting company | ☐ | Emerging growth company | ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ
As of April 28, 2023, Welltower Inc. had 497,031,161 shares of common stock outstanding.
TABLE OF CONTENTS
| | | | | | | | |
| | |
PART I. FINANCIAL INFORMATION | Page |
| | |
Item 1. Financial Statements (Unaudited) | |
| | |
| Consolidated Balance Sheets | |
| | |
| Consolidated Statements of Comprehensive Income | |
| | |
| Consolidated Statements of Equity | |
| | |
| Consolidated Statements of Cash Flows | |
| | |
| Notes to Unaudited Consolidated Financial Statements | |
| | |
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | |
| | |
Item 3. Quantitative and Qualitative Disclosures About Market Risk | |
| |
Item 4. Controls and Procedures | |
| | |
PART II. OTHER INFORMATION | |
| | |
Item 1. Legal Proceedings | |
| | |
Item 1A. Risk Factors | |
| | |
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | |
| | |
Item 5. Other Information | |
| | |
Item 6. Exhibits | |
| | |
Signatures | |
PART I. FINANCIAL INFORMATION
CONSOLIDATED BALANCE SHEETS
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
| | | | | | | | | | | | | | |
| | March 31, 2023 (Unaudited) | | December 31, 2022 (Note) |
Assets: | | | | |
Real estate investments: | | | | |
Real property owned: | | | | |
Land and land improvements | | $ | 4,324,541 | | | $ | 4,249,834 | |
Buildings and improvements | | 34,161,466 | | | 33,651,336 | |
Acquired lease intangibles | | 1,990,830 | | | 1,945,458 | |
Real property held for sale, net of accumulated depreciation | | 215,583 | | | 133,058 | |
Construction in progress | | 1,121,446 | | | 1,021,080 | |
Less accumulated depreciation and amortization | | (8,417,151) | | | (8,075,733) | |
Net real property owned | | 33,396,715 | | | 32,925,033 | |
Right of use assets, net | | 322,896 | | | 323,942 | |
Real estate loans receivable, net of credit allowance | | 954,156 | | | 890,844 | |
Net real estate investments | | 34,673,767 | | | 34,139,819 | |
Other assets: | | | | |
Investments in unconsolidated entities | | 1,596,413 | | | 1,499,790 | |
Goodwill | | 68,321 | | | 68,321 | |
Cash and cash equivalents | | 571,902 | | | 631,681 | |
Restricted cash | | 66,894 | | | 90,611 | |
Straight-line rent receivable | | 357,359 | | | 322,173 | |
Receivables and other assets | | 1,159,233 | | | 1,140,838 | |
Total other assets | | 3,820,122 | | | 3,753,414 | |
Total assets | | $ | 38,493,889 | | | $ | 37,893,233 | |
| | | | |
Liabilities and equity | | | | |
Liabilities: | | | | |
Unsecured credit facility and commercial paper | | $ | — | | | $ | — | |
Senior unsecured notes | | 12,486,229 | | | 12,437,273 | |
Secured debt | | 2,474,837 | | | 2,110,815 | |
Lease liabilities | | 415,169 | | | 415,824 | |
Accrued expenses and other liabilities | | 1,521,499 | | | 1,535,325 | |
Total liabilities | | 16,897,734 | | | 16,499,237 | |
Redeemable noncontrolling interests | | 392,195 | | | 384,443 | |
Equity: | | | | |
Common stock | | 497,928 | | | 491,919 | |
Capital in excess of par value | | 27,160,014 | | | 26,742,750 | |
Treasury stock | | (112,925) | | | (111,001) | |
Cumulative net income | | 8,830,623 | | | 8,804,950 | |
Cumulative dividends | | (15,815,926) | | | (15,514,097) | |
Accumulated other comprehensive income (loss) | | (111,559) | | | (119,707) | |
Total Welltower Inc. stockholders’ equity | | 20,448,155 | | | 20,294,814 | |
Noncontrolling interests | | 755,805 | | | 714,739 | |
Total equity | | 21,203,960 | | | 21,009,553 | |
Total liabilities and equity | | $ | 38,493,889 | | | $ | 37,893,233 | |
Note: The consolidated balance sheet at December 31, 2022 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands, except per share data)
| | | | | | | | | | | | | | | | | | |
| | | | Three Months Ended |
| | | | March 31, |
| | | | | | 2023 | | 2022 |
Revenues: | | | | | | | | |
Resident fees and services | | | | | | $ | 1,131,685 | | | $ | 994,335 | |
Rental income | | | | | | 384,059 | | | 356,390 | |
Interest income | | | | | | 36,405 | | | 38,994 | |
Other income | | | | | | 8,580 | | | 5,985 | |
Total revenues | | | | | | 1,560,729 | | | 1,395,704 | |
| | | | | | | | |
Expenses: | | | | | | | | |
Property operating expenses | | | | | | 957,753 | | | 853,669 | |
Depreciation and amortization | | | | | | 339,112 | | | 304,088 | |
Interest expense | | | | | | 144,403 | | | 121,696 | |
General and administrative expenses | | | | | | 44,371 | | | 37,706 | |
Loss (gain) on derivatives and financial instruments, net | | | | | | 930 | | | 2,578 | |
Loss (gain) on extinguishment of debt, net | | | | | | 5 | | | (12) | |
Provision for loan losses, net | | | | | | 777 | | | (804) | |
Impairment of assets | | | | | | 12,629 | | | — | |
Other expenses | | | | | | 22,745 | | | 26,069 | |
Total expenses | | | | | | 1,522,725 | | | 1,344,990 | |
| | | | | | | | |
Income (loss) from continuing operations before income taxes and other items | | | | | | 38,004 | | | 50,714 | |
Income tax (expense) benefit | | | | | | (3,045) | | | (5,013) | |
Income (loss) from unconsolidated entities | | | | | | (7,071) | | | (2,884) | |
Gain (loss) on real estate dispositions, net | | | | | | 747 | | | 22,934 | |
Income (loss) from continuing operations | | | | | | 28,635 | | | 65,751 | |
| | | | | | | | |
Net income (loss) | | | | | | 28,635 | | | 65,751 | |
Less: Net income (loss) attributable to noncontrolling interests(1) | | | | | | 2,962 | | | 3,826 | |
Net income (loss) attributable to common stockholders | | | | | | $ | 25,673 | | | $ | 61,925 | |
| | | | | | | | |
Weighted average number of common shares outstanding: | | | | | | | | |
Basic | | | | | | 492,061 | | | 447,379 | |
Diluted | | | | | | 494,494 | | | 449,802 | |
| | | | | | | | |
Earnings per share: | | | | | | | | |
Basic: | | | | | | | | |
Income (loss) from continuing operations | | | | | | $ | 0.06 | | | $ | 0.15 | |
Net income (loss) attributable to common stockholders | | | | | | $ | 0.05 | | | $ | 0.14 | |
| | | | | | | | |
Diluted: | | | | | | | | |
Income (loss) from continuing operations | | | | | | $ | 0.06 | | | $ | 0.15 | |
Net income (loss) attributable to common stockholders(2) | | | | | | $ | 0.05 | | | $ | 0.14 | |
| | | | | | | | |
Dividends declared and paid per common share | | | | | | $ | 0.61 | | | $ | 0.61 | |
(1) Includes amounts attributable to redeemable noncontrolling interests.
(2) Includes adjustment to the numerator for income (loss) attributable to OP Units and DownREIT Units.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
| | | | | | | | | | | | | | | | | | |
| | | | Three Months Ended |
| | | | March 31, |
| | | | | | 2023 | | 2022 |
Net income (loss) | | | | | | $ | 28,635 | | | $ | 65,751 | |
| | | | | | | | |
Other comprehensive income (loss): | | | | | | | | |
Foreign currency translation gain (loss) | | | | | | 80,765 | | | (66,948) | |
Derivative and financial instruments designated as hedges gain (loss) | | | | | | (69,738) | | | 51,940 | |
Total other comprehensive income (loss) | | | | | | 11,027 | | | (15,008) | |
| | | | | | | | |
Total comprehensive income (loss) | | | | | | 39,662 | | | 50,743 | |
Less: Total comprehensive income (loss) attributable to noncontrolling interests(1) | | | | | | 5,841 | | | 5,974 | |
Total comprehensive income (loss) attributable to common stockholders | | | | | | $ | 33,821 | | | $ | 44,769 | |
| | | | | | | | |
(1) Includes amounts attributable to redeemable noncontrolling interests. | | | | | | | | |
CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, 2023 |
| | Common Stock | | Capital in Excess of Par Value | | Treasury Stock | | Cumulative Net Income | | Cumulative Dividends | | Accumulated Other Comprehensive Income (Loss) | | Noncontrolling Interests | | Total |
Balances at January 1, 2023 | | $ | 491,919 | | | $ | 26,742,750 | | | $ | (111,001) | | | $ | 8,804,950 | | | $ | (15,514,097) | | | $ | (119,707) | | | $ | 714,739 | | | $ | 21,009,553 | |
Comprehensive income: | | | | | | | | | | | | | | | | |
Net income (loss) | | | | | | | | | | | 25,673 | | | | | | | | | 2,688 | | | 28,361 | |
Other comprehensive income (loss) | | | | | | | | | | | | | | | | | 8,148 | | | 3,023 | | | 11,171 | |
Total comprehensive income | | | | | | | | | | | | | | | | | | | | | | | 39,532 | |
Net change in noncontrolling interests | | | | | (8,304) | | | | | | | | | | | | | | | 29,648 | | | 21,344 | |
Adjustment to members' interest from change in ownership in Welltower OP | | | | | (6,139) | | | | | | | | | | | | | | | 6,139 | | | — | |
Redemption of OP Units and DownREIT Units | | 272 | | | 17,515 | | | | | | | | | | | | | | | (432) | | | 17,355 | |
Amounts related to stock incentive plans, net of forfeitures | | 134 | | | 9,330 | | | (1,924) | | | | | | | | | | | | | | | 7,540 | |
Net proceeds from issuance of common stock | | 5,603 | | | 404,862 | | | | | | | | | | | | | | | | | | 410,465 | |
Dividends paid: | | | | | | | | | | | | | | | | |
Common stock dividends | | | | | | | | | | | | | | (301,829) | | | | | | | | | (301,829) | |
Balances at March 31, 2023 | | $ | 497,928 | | | $ | 27,160,014 | | | $ | (112,925) | | | $ | 8,830,623 | | | $ | (15,815,926) | | | $ | (111,559) | | | $ | 755,805 | | | $ | 21,203,960 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended March 31, 2022 |
| | Common Stock | | Capital in Excess of Par Value | | Treasury Stock | | Cumulative Net Income | | Cumulative Dividends | | Accumulated Other Comprehensive Income (Loss) | | Noncontrolling Interests | | Total |
Balances at January 1, 2022 | | $ | 448,605 | | | $ | 23,133,641 | | | $ | (107,750) | | | $ | 8,663,736 | | | $ | (14,380,915) | | | $ | (121,316) | | | $ | 960,578 | | | $ | 18,596,579 | |
Comprehensive income: | | | | | | | | | | | | | | | | |
Net income (loss) | | | | | | | | 61,925 | | | | | | | 2,752 | | | 64,677 | |
Other comprehensive income (loss) | | | | | | | | | | | | (17,156) | | | 1,465 | | | (15,691) | |
Total comprehensive income | | | | | | | | | | | | | | | | 48,986 | |
Net change in noncontrolling interests | | | | (63,026) | | | | | | | | | | | (128,305) | | | (191,331) | |
Amounts related to stock incentive plans, net of forfeitures | | 166 | | | 7,279 | | | (4,768) | | | | | | | | | | | 2,677 | |
Net proceeds from issuance of common stock | | 6,605 | | | 542,218 | | | | | | | | | | | | | 548,823 | |
Dividends paid: | | | | | | | | | | | | | | | | |
Common stock dividends | | | | | | | | | | (273,668) | | | | | | | (273,668) | |
Balances at March 31, 2022 | | $ | 455,376 | | | $ | 23,620,112 | | | $ | (112,518) | | | $ | 8,725,661 | | | $ | (14,654,583) | | | $ | (138,472) | | | $ | 836,490 | | | $ | 18,732,066 | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | |
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
WELLTOWER INC. AND SUBSIDIARIES
(In thousands)
| | | | | | | | | | | | | | |
| | Three Months Ended |
| | March 31, |
| | 2023 | | 2022 |
Operating activities: | | | | |
Net income | | $ | 28,635 | | | $ | 65,751 | |
Adjustments to reconcile net income to net cash provided from (used in) operating activities: | | | | |
Depreciation and amortization | | 339,112 | | | 304,088 | |
Other amortization expenses | | 9,792 | | | 5,592 | |
Provision for loan losses, net | | 777 | | | (804) | |
Impairment of assets | | 12,629 | | | — | |
Stock-based compensation expense | | 9,456 | | | 7,445 | |
Loss (gain) on derivatives and financial instruments, net | | 930 | | | 2,578 | |
Loss (gain) on extinguishment of debt, net | | 5 | | | (12) | |
Loss (income) from unconsolidated entities | | 7,071 | | | 2,884 | |
Rental income less than (in excess of) cash received | | (36,827) | | | (22,215) | |
Amortization related to above (below) market leases, net | | (82) | | | (419) | |
Loss (gain) on real estate dispositions, net | | (747) | | | (22,934) | |
Distributions by unconsolidated entities | | 3,418 | | | 6,982 | |
Increase (decrease) in accrued expenses and other liabilities | | (4,503) | | | (23,416) | |
Decrease (increase) in receivables and other assets | | 6,392 | | | (1,000) | |
Net cash provided from (used in) operating activities | | 376,058 | | | 324,520 | |
| | | | |
Investing activities: | | | | |
Cash disbursed for acquisitions, net of cash acquired | | (402,719) | | | (601,410) | |
Cash disbursed for capital improvements to existing properties | | (91,339) | | | (90,229) | |
Cash disbursed for construction in progress | | (226,226) | | | (138,141) | |
Capitalized interest | | (10,335) | | | (5,479) | |
Investment in loans receivable | | (54,831) | | | (39,201) | |
Principal collected on loans receivable | | 15,592 | | | 89,207 | |
Other investments, net of payments | | (80,548) | | | 2,401 | |
Contributions to unconsolidated entities | | (112,822) | | | (115,249) | |
Distributions by unconsolidated entities | | 4,800 | | | 5,882 | |
Proceeds from (payments on) derivatives | | 3,933 | | | 10,104 | |
Proceeds from sales of real property | | 21,658 | | | 73,568 | |
Net cash provided from (used in) investing activities | | (932,837) | | | (808,547) | |
| | | | |
Financing activities: | | | | |
Net increase (decrease) under unsecured credit facility and commercial paper | | — | | | (24,967) | |
Net proceeds from issuance of senior unsecured notes | | — | | | 545,082 | |
| | | | |
Net proceeds from the issuance of secured debt | | 362,900 | | | 5,385 | |
Payments on secured debt | | (39,573) | | | (116,789) | |
Net proceeds from the issuance of common stock | | 411,032 | | | 549,346 | |
| | | | |
Payments for deferred financing costs and prepayment penalties | | (6,444) | | | (69) | |
Contributions by noncontrolling interests(1) | | 83,480 | | | 4,101 | |
Distributions to noncontrolling interests(1) | | (35,664) | | | (177,979) | |
| | | | |
Cash distributions to stockholders | | (300,195) | | | (273,045) | |
Other financing activities | | (5,066) | | | (5,960) | |
Net cash provided from (used in) financing activities | | 470,470 | | | 505,105 | |
Effect of foreign currency translation on cash and cash equivalents and restricted cash | | 2,813 | | | (790) | |
Increase (decrease) in cash, cash equivalents and restricted cash | | (83,496) | | | 20,288 | |
Cash, cash equivalents and restricted cash at beginning of period | | 722,292 | | | 346,755 | |
Cash, cash equivalents and restricted cash at end of period | | $ | 638,796 | | | $ | 367,043 | |
| | | | |
Supplemental cash flow information: | | | | |
Interest paid | | $ | 148,399 | | | $ | 123,012 | |
Income taxes paid (received), net | | 325 | | | 631 | |
| | | | |
(1) Includes amounts attributable to redeemable noncontrolling interests. | | | | |
WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
1. Business
Welltower Inc., an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. We invest with leading seniors housing operators, post-acute providers and health systems to fund the real estate and infrastructure needed to scale innovative care delivery models and improve people’s wellness and overall health care experience. Welltower Inc., a real estate investment trust (“REIT”), owns interests in properties concentrated in major, high-growth markets in the United States (“U.S.”), Canada and the United Kingdom (“U.K.”), consisting of seniors housing and post-acute communities and outpatient medical properties.
As of May 24, 2022, we are structured as an umbrella partnership REIT under which substantially all of our business is conducted through Welltower OP LLC, the day-to-day management of which is exclusively controlled by Welltower Inc. Unless stated otherwise or the context otherwise requires, references to "Welltower" mean Welltower Inc. and references to "Welltower OP" mean Welltower OP LLC. References to "we," "us" and "our" mean collectively Welltower, Welltower OP and those entities/subsidiaries owned or controlled by Welltower and/or Welltower OP. Welltower's weighted average ownership in Welltower OP was 99.735% for the three months ended March 31, 2023. As of March 31, 2023, Welltower owned 99.721% of the issued and outstanding units of Welltower OP, with other investors owning the remaining 0.279% of outstanding units. We adjust the noncontrolling members' interest at the end of each period to reflect their interest in the net assets of Welltower OP.
2. Accounting Policies and Related Matters
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (such as normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2023 are not necessarily an indication of the results that may be expected for the year ending December 31, 2023. For further information, refer to the financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2022.
Impact of COVID-19 Pandemic & Government Grants
The extent to which the COVID-19 pandemic impacts our operations and those of our operators and tenants in the future is uncertain and cannot be predicted with confidence. We have received government grants under the CARES Act, as well as under similar programs in the U.K. and Canada, primarily to cover increased expenses and lost revenue during the COVID-19 pandemic. We recognized $4,136,000 and $5,760,000 during the three months ended March 31, 2023 and 2022, respectively. These grants represent a reduction to property operating expenses in our Consolidated Statements of Comprehensive Income. The amount of qualifying expenditures and lost revenue exceeded grant income recognized and we believe we have complied and will continue to comply with all grant conditions. In the event of non-compliance, all such amounts are subject to recapture.
New Accounting Standards
In March 2020, the FASB issued an amendment to the reference rate reform standard, which provides the option for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of, reference rate reform on contract modifications and hedge accounting. An example of such reform is the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. Entities that make this optional expedient election would not have to remeasure the contracts at the modification date or reassess the accounting treatment if certain criteria are met and would continue applying hedge accounting for relationships affected by reference rate reform. In December 2022, the FASB extended the date for which this guidance can be applied from December 31, 2022 to December 31, 2024. We continue to monitor developments related to the LIBOR transition and identification of an alternative, market-accepted rate.
3. Real Property Acquisitions and Development
The total purchase price for all properties acquired has been allocated to the tangible and identifiable intangible assets and liabilities at cost on a relative fair value basis. Liabilities assumed and any associated noncontrolling interests are reflected at fair value. The results of operations for these acquisitions have been included in our consolidated results of operations since the date of acquisition and are a component of the appropriate segments. Transaction costs primarily represent costs incurred with acquisitions, including due diligence costs, fees for legal and valuation services, termination of pre-existing relationships computed based on the fair value of the assets acquired, lease termination fees and other acquisition-related costs. Transaction costs related to asset acquisitions are capitalized as a component of purchase price and all other non-capitalizable costs are reflected in other expenses on our Consolidated Statements of Comprehensive Income.
WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
The following is a summary of our real property investment activity by segment for the periods presented (in thousands):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Three Months Ended |
| March 31, 2023 | | March 31, 2022 |
| Seniors Housing Operating | | Triple-net | | Outpatient Medical | | Totals | | Seniors Housing Operating | | Triple-net | | Outpatient Medical | | Totals |
Land and land improvements | $ | 2,517 | | | $ | 7,370 | | | $ | 60,527 | | | $ | 70,414 | | | $ | 43,897 | | | $ | — | | | $ | 240 | | | $ | 44,137 | |
Buildings and improvements | 16,434 | | | 74,289 | | | 255,706 | | | 346,429 | | | 402,342 | | | 171 | | | 131,412 | | | 533,925 | |
Acquired lease intangibles | 865 | | | — | | | 39,090 | | | 39,955 | | | 31,366 | | | — | | | 16,978 | | | 48,344 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
Right of use assets, net | — | | | — | | | 927 | | | 927 | | | — | | | — | | | 3,852 | | | 3,852 | |
Total net real estate assets | 19,816 | | | 81,659 | | | 356,250 | | | 457,725 | | | 477,605 | | | 171 | | | 152,482 | | | 630,258 | |
Receivables and other assets | 234 | | | — | | | 358 | | | 592 | | | 1,630 | | | — | | | — | | | 1,630 | |
Total assets acquired | 20,050 | | | 81,659 | | | 356,608 | | | 458,317 | | | 479,235 | | | 171 | | | 152,482 | | | 631,888 | |
Secured debt | (5,501) | | | — | | | (40,953) | | | (46,454) | | | — | | | — | | | — | | | — | |
Lease liabilities | — | | | — | | | (953) | | | (953) | | | — | | | — | | | (3,852) | | | (3,852) | |
Accrued expenses and other liabilities | (120) | | | — | | | (8,071) | | | (8,191) | | | (4,154) | | | — | | | — | | | (4,154) | |
Total liabilities acquired | (5,621) | | | — | | | (49,977) | | | (55,598) | | | (4,154) | | | — | | | (3,852) | | | (8,006) | |
Noncontrolling interests (1) | — | | | — | | | — | | | — | | | (20,348) | | | (4) | | | — | | | (20,352) | |
Non-cash acquisition related activity(2) | — | | | — | | | — | | | — | | | (2,120) | | | — | | | — | | | (2,120) | |
Cash disbursed for acquisitions | 14,429 | | | 81,659 | | | 306,631 | | | 402,719 | | | 452,613 | | | 167 | | | 148,630 | | | 601,410 | |
Construction in progress additions | 131,944 | | | 4,995 | | | 101,609 | | | 238,548 | | | 113,407 | | | 20,756 | | | 9,642 | | | 143,805 | |
Less: Capitalized interest | (7,950) | | | (1,248) | | | (1,137) | | | (10,335) | | | (4,179) | | | (1,089) | | | (211) | | | (5,479) | |
Accruals (3) | 2,303 | | | — | | | (4,290) | | | (1,987) | | | (1,963) | | | — | | | 1,778 | | | (185) | |
Cash disbursed for construction in progress | 126,297 | | | 3,747 | | | 96,182 | | | 226,226 | | | 107,265 | | | 19,667 | | | 11,209 | | | 138,141 | |
Capital improvements to existing properties | 69,783 | | | 4,427 | | | 17,129 | | | 91,339 | | | 68,612 | | | 8,294 | | | 13,323 | | | 90,229 | |
Total cash invested in real property, net of cash acquired | $ | 210,509 | | | $ | 89,833 | | | $ | 419,942 | | | $ | 720,284 | | | $ | 628,490 | | | $ | 28,128 | | | $ | 173,162 | | | $ | 829,780 | |
(1) Includes amounts attributable to both redeemable noncontrolling interests and noncontrolling interests.
(2) Relates to the acquisition of assets recognized as investments in unconsolidated entities.
(3) Represents non-cash accruals for amounts to be paid in future periods for properties that converted, offset by amounts paid in the current period.
Effective on April 1, 2022, our leasehold interest relating to the master lease with National Health Investors, Inc. ("NHI") for 17 properties assumed in conjunction with the Holiday Retirement acquisition was terminated as a result of the transition or sale of the properties by NHI. The lease termination was part of an agreement to resolve outstanding litigation with NHI. In conjunction with the agreement, a wholly owned subsidiary and the lessee on the master lease agreed to release $6,883,000 of cash to the landlord, which represents the net cash flow generated from the properties since we assumed the leasehold interest. Additionally, in connection with the lease termination, during the three months ended June 30, 2022, we recognized $58,621,000 in other income on our Consolidated Statements of Comprehensive Income from the derecognition of the right of use asset and related lease liability.
Construction Activity
The following is a summary of the construction projects that were placed into service and began generating revenues during the periods presented (in thousands):
| | | | | | | | | | | | | | |
| | Three Months Ended |
| | March 31, 2023 | | March 31, 2022 |
Development projects: | | | | |
Seniors Housing Operating | | $ | 26,712 | | | $ | 73,458 | |
| | | | |
Outpatient Medical | | 9,351 | | | — | |
Total development projects | | 36,063 | | | 73,458 | |
Expansion projects | | 17,245 | | | — | |
Total construction in progress conversions | | $ | 53,308 | | | $ | 73,458 | |
WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
4. Real Estate Intangibles
The following is a summary of our real estate intangibles, excluding those related to ground leases or classified as held for sale, as of the dates indicated (dollars in thousands):
| | | | | | | | | | | | | | |
| | March 31, 2023 | | December 31, 2022 |
Assets: | | | | |
In place lease intangibles | | $ | 1,846,945 | | | $ | 1,817,580 | |
Above market tenant leases | | 66,354 | | | 57,203 | |
Lease commissions | | 77,531 | | | 70,675 | |
Gross historical cost | | 1,990,830 | | | 1,945,458 | |
Accumulated amortization | | (1,543,457) | | | (1,484,048) | |
Net book value | | $ | 447,373 | | | $ | 461,410 | |
| | | | |
Liabilities: | | | | |
Below market tenant leases | | $ | 82,084 | | | $ | 77,985 | |
Accumulated amortization | | (54,872) | | | (52,701) | |
Net book value | | $ | 27,212 | | | $ | 25,284 | |
The following is a summary of real estate intangible amortization income (expense) for the periods presented (in thousands):
| | | | | | | | | | | | | | | | | | |
| | | | Three Months Ended March 31, |
| | | | | | 2023 | | 2022 |
Rental income related to (above)/below market tenant leases, net | | | | | | $ | 45 | | | $ | 385 | |
Amortization related to in place lease intangibles and lease commissions | | | | | | (56,151) | | | (47,994) | |
5. Dispositions, Real Property Held for Sale and Impairment
We periodically sell properties for various reasons, including favorable market conditions, the exercise of tenant purchase options or reduction of concentrations (i.e., property type, relationship or geography). At March 31, 2023, five Seniors Housing Operating properties, seven Triple-net properties and one Outpatient Medical property with an aggregate real estate balance of $215,583,000 were classified as held for sale. In addition to the real property balances, lease liabilities of $66,530,000 and net other assets and (liabilities) of $6,095,000 are included in the Consolidated Balance Sheets related to the held for sale properties. Expected gross sales proceeds related to the held for sale properties are approximately $292,623,000.
During the three months ended March 31, 2023, we recorded $12,629,000 of impairment charges related to three Seniors Housing Operating properties classified as held for sale for which the carrying value exceeded the estimated fair value less costs to sell and one Seniors Housing Operating property classified as held for use for which the carrying value exceeded the estimated fair value. We did not record any impairment charges during the three months ended March 31, 2022.
The following is a summary of our real property disposition activity for the periods presented (in thousands):
| | | | | | | | | | | | | | |
| | Three Months Ended |
| | March 31, 2023 | | March 31, 2022 |
Real estate dispositions: | | | | |
Seniors Housing Operating | | $ | 18,572 | | | $ | — | |
Triple-net | | 2,028 | | | 52,661 | |
| | | | |
Total dispositions | | 20,600 | | | 52,661 | |
Gain (loss) on real estate dispositions, net | | 747 | | | 22,934 | |
Net other assets/(liabilities) disposed | | 311 | | | (2,027) | |
Proceeds from real estate dispositions | | $ | 21,658 | | | $ | 73,568 | |
Operating results attributable to properties sold or classified as held for sale which do not meet the definition of discontinued operations are not reclassified on our Consolidated Statements of Comprehensive Income. We recognized income (loss) from continuing operations before income taxes and other items from properties sold or classified as held for sale as of March 31, 2023 of $(11,733,000) and $1,337,000 for the three month periods ended March 31, 2023 and 2022, respectively.
WELLTOWER INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS
6. Leases
We lease land, buildings, office space and certain equipment. Many of our leases include a renewal option to extend the term from one to 25 years or more. Renewal options that we are reasonably certain to exercise are recognized in our right-of-use assets and lease liabilities.
The components of lease expense were as follows for the periods presented (in thousands):
| | | | | | | | | | | | | | | | | | | | |
| | | | Three Months Ended |
| | Classification | | March 31, 2023 | | March 31, 2022 |
Operating lease cost: (1) | | | | | | |
Real estate lease expense | | Property operating expenses | | $ | 5,520 | | | $ | 5,816 | |
Non-real estate investment lease expense | | General and administrative expenses | | 1,863 | | | 978 | |
Finance lease cost: | | | | | | |
Amortization of leased assets | | Property operating expenses | | 2,284 | | | 1,156 | |
Interest on lease liabilities | | Interest expense | | 1,427 | | | 1,618 | |
Sublease income | | Rental income | | (2,950) | | | (2,715) | |
Total | | | | $ | 8,144 | | | $ | 6,853 | |
(1) Includes short-term leases which are immaterial.
Supplemental balance sheet information related to leases in which we are the lessee is as follows (in thousands):
| | | | | | | | | | | | | | | | | |
| Classification | | March 31, 2023 | | December 31, 2022 |
Right of use assets: | | | | | |
Operating leases - real estate | Right of use assets, net | | $ | 287,275 | | | $ | 287,984 | |
Finance leases - real estate | Right of use assets, net | | 35,621 | | | 35,958 | |
Real estate right of use assets, net | | | 322,896 | | | 323,942 | |
Operating leases - non-real estate investments | Receivables and other assets | | 9,281 | | | 10,119 | |
Finance leases - held for sale (1) | Real property held for sale, net of accumulated depreciation | | 115,359 | | | 116,453 | |
Total right of use assets, net | | | $ | 447,536 | | | $ | 450,514 | |
| | | | | |
Lease liabilities: | | | | | |
Operating leases | | | $ | 301,915 | | | $ | 302,360 | |
|